Health Condition 1: N186- End stage renal disease
Conditions
Interventions
Intervention1: Home Medication Review: Home Medication Review is a consumer-focused, organized and collaborative healthcare service provided in the community-setting that offers a potential approach t
Sponsors
Centre for Toxicovigilance and Drug Safety
Eligibility
Inclusion criteria
Inclusion criteria: ESRD patients undergoing dialysis treatment for 2-3 sessions per week. ESRD patients who are 18 years and above. ESRD patients who are able to talk and give consent
Exclusion criteria
Exclusion criteria: The patients who are not undergoing dialysis treatment. Pediatric ESRD patients ESRD patients who are bedridden. ESRD patients who are paralyzed. ESRD patients who are not willing to give consent due to other reasons. The patients who are having cultural limitations.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcome of the study is the assessment of reduction in the cost between pre and post intervention.Timepoint: The patients will be followed-up in 4 time-points. Firstly, before providing the intervention and 3,6 and 12 months after providing the intervention. | — |
Secondary
| Measure | Time frame |
|---|---|
| The secondary outcome of the study is to assess the Quality of Life of the patients between pre and post intervention.Timepoint: The patients will be followed-up in 4 time-points. Firstly, before providing the intervention and 3,6 and 12 months after providing the intervention. | — |
Countries
India
Contacts
Public ContactDr Girish Thunga
Manipal College of Pharmaceutical Sciences
Outcome results
None listed